ReviewMolecular and cellular biochemistry
Mitogen-activated protein kinase (MAPK) in cardiac tissues.
Review in Molecular and cellular biochemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 52 citations in OpenAlex.
- Multi-Omics Analysis Reveals the Role of Sigma-1 Receptor in a Takotsubo-like Cardiomyopathy Model.Biomedicines · 2023Article
- Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.Current treatment options in cardiovascular medicine · 2017Review
- Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells.Oncology letters · 2016Article
- Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation.Endocrine · 2015Article
- Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension.Current vascular pharmacology · 2015Article
- Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway.Experimental and therapeutic medicine · 2014Article
- Retinol binding protein 4 promotes hyperinsulinism‑induced proliferation of rat aortic smooth muscle cells.Molecular medicine reports · 2014Article
- Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats.Evidence-based complementary and alternative medicine : eCAM · 2014Article
- Caveolin and caveolae in age associated cardiovascular disease.Journal of geriatric cardiology : JGC · 2013Article
- Gene expression profiling of the proliferative effect of periplocin on mouse cardiac microvascular endothelial cells.Chinese journal of integrative medicine · 2010Article
- Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2005Article
- Various stressors rapidly activate the p38-MAPK signaling pathway in Mytilus galloprovincialis (Lam.).Molecular and cellular biochemistry · 2004Article
- Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes.Molecular and cellular biochemistry · 2001Article
- Activation of multiple MAPK pathways (ERKs, JNKs, p38-MAPK) by diverse stimuli in the amphibian heart.Molecular and cellular biochemistry · 2001Article
- Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.Proceedings of the National Academy of Sciences of the United States of America · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitogen-activated protein kinase (MAPK) has recently emerged as a prominent role player in intracellular signalling in the ventricular myocyte with attention being focussed on its possible role in the development of ventricular hypertrophy. It is becoming clear that MAPK is also active in other cells of cardiac origin such as cardiac fibroblasts and possible functions of this signalling pathway in the heart have yet to be explored. In this report the mammalian MAPK pathway is briefly outlined, before reviewing current knowledge of the MAPK pathway in cardiac tissue (ventricular myocytes, vascular smooth muscle cells and cardiac fibroblasts). New data is also presented on the presence and activity of MAPK in two additional cardiac celltypes namely atrial myocytes and vascular endothelial cells from the coronary microcirculation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.